Trump announces trade deal with EU following months of negotiations
Cathie Wood’s ARK ETFs have made significant moves in the market on Monday, March 10th, 2025, with a series of buys and sells that indicate a strategic adjustment to their investment portfolio. Leading the purchases was an increase in Tesla Inc (NASDAQ:TSLA) shares, with ARK buying 79,318 shares valued at approximately $20,834,460. This purchase aligns with ARK’s continued confidence in the electric vehicle industry and Tesla’s leading role within it.
Following closely was a substantial investment in Coinbase Global Inc (NASDAQ:COIN), with ARK acquiring 64,358 shares for a total of $13,994,646. This move suggests ARK’s ongoing bullish stance on the cryptocurrency exchange platform, despite the volatile nature of the digital currency market.
In another notable transaction, ARK expanded its holdings in Advanced Micro Devices Inc (NASDAQ:AMD), buying a total of 147,551 shares across multiple ETFs, amounting to $14,800,840. This purchase could reflect ARK’s positive outlook on the semiconductor industry and AMD’s competitive positioning.
ARK also focused on the biotechnology sector, adding 485,005 shares of Beam Therapeutics Inc (NASDAQ:BEAM) valued at $13,812,942, and 269,864 shares of Robinhood Markets Inc (NASDAQ:HOOD) at a value of $11,987,358. These acquisitions underscore ARK’s interest in innovative companies with disruptive potential.
On the sell side, the largest transaction was the divestment of SoFi Technologies Inc (NASDAQ:SOFI), with ARK selling a staggering 5,527,814 shares, leading to a total sale value of $69,595,179. This move could indicate a strategic shift or a response to recent market or company-specific events.
Additionally, ARK reduced its stake in Block Inc (NYSE:SQ), offloading 376,607 shares for a value of $22,596,420. This sale might reflect ARK’s portfolio rebalancing or a change in its assessment of the financial technology company’s outlook.
Other sales included positions in UiPath Inc (NYSE:PATH), Kratos Defense and Security Solutions Inc (NASDAQ:KTOS), and Veracyte Inc (NASDAQ:VCYT), totaling $7,122,738, $1,545,596, and $2,967,261, respectively. These transactions could be part of ARK’s regular portfolio management practices or reactions to market conditions.
The report also shows a continuation of trends from the previous week, with ARK consistently buying shares of Absci Corp (NASDAQ:ABSI) and Recursion Pharmaceuticals Inc (NASDAQ:RXRX), indicating a longer-term investment strategy in these companies.
Investors following Cathie Wood’s ARK ETFs will be keen to see how these trades play out in the context of the broader market and ARK’s innovative investment philosophy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.